dc.contributor.advisor | Karim, Eshaba | |
dc.contributor.author | Jony, Md. Nazmul Islam | |
dc.date.accessioned | 2023-04-06T08:19:58Z | |
dc.date.available | 2023-04-06T08:19:58Z | |
dc.date.copyright | 2021 | |
dc.date.issued | 2021-02 | |
dc.identifier.other | ID: 16146041 | |
dc.identifier.uri | http://hdl.handle.net/10361/18100 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 29-30). | |
dc.description.abstract | The Food and Drug Administration (FDA) is responsible for protecting and ensuring the
safety of the American public health by approving and monitoring drug products. They do so
with strict supervision. This study was done to find out any correlation between drug
products approved by FDA and the nature of disease. Since chronic diseases are growing in
global prevalence and directly threatening the health of the world population, this study
attempted to identify if the most frequently approved drug products are for the treatment of
such diseases. Data was collected from the official FDA website and analyzed to find out
how frequently products containing each active pharmaceutical ingredient were approved.
The ATC codes for the APIs were enlisted. This was used to identify their therapeutic
classes. Most of the therapeutic classes suggested that the FDA has indeed approved more
drug products for the treatment of chronic diseases than acute diseases. | en_US |
dc.description.statementofresponsibility | Md. Nazmul Islam Jony | |
dc.format.extent | 30 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | FDA | en_US |
dc.subject | Chronic Diseases | en_US |
dc.subject | Global Prevalence | en_US |
dc.subject | Unique API List | en_US |
dc.subject | ATC codes | en_US |
dc.subject | Therapeutic Classes | en_US |
dc.subject.lcsh | United States. Food and Drug Administration. | |
dc.title | A study on drug product approval by the FDA from 1930 to 2019 | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Department of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |